Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Amnesia, Anterograde D020324 2 associated lipids
Migraine without Aura D020326 1 associated lipids
Enterocolitis, Necrotizing D020345 3 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Stroke D020521 32 associated lipids
Fetal Weight D020567 12 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Egg Hypersensitivity D021181 1 associated lipids
Peanut Hypersensitivity D021183 2 associated lipids
Coronary Stenosis D023921 6 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Joseph R et al. Sensitivity to PAF is increased in migraine patients. 1987 Thromb. Haemost. pmid:3590077
Taylor RR et al. Time dependence of whole blood aggregation in response to platelet activating factor (PAF). 1988 Thromb. Haemost. pmid:3388292
Powling MJ and Hardisty RM Potentiation by adrenaline of Ca2+ influx and mobilization in stimulated human platelets: dissociation from thromboxane generation and aggregation. 1988 Thromb. Haemost. pmid:3388294
Hornby EJ and Perry CR 1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen. 1983 Thromb. Haemost. pmid:6636035
Cargill DI et al. Aggregation, release and desensitization induced in platelets from five species by platelet activating factor (PAF). 1983 Thromb. Haemost. pmid:6879508
Shindo K et al. Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor. 1997 Thorax pmid:9516893
Chung KF Platelet activating factor revisited. 1997 Thorax pmid:9516891
Shindo K et al. Priming effect of platelet activating factor on leukotriene C4 from stimulated eosinophils of asthmatic patients. 1996 Thorax pmid:8711647
McFadden RG et al. Effect of platelet activating factor (PAF) on the migration of human lymphocytes. 1995 Thorax pmid:7660340
Spring J et al. Failure of salmeterol to inhibit circulating white cell responses and bronchoconstriction induced by platelet activating factor. 1992 Thorax pmid:1361250
Chung KF et al. Effects of salbutamol on bronchoconstriction, bronchial hyperresponsiveness, and leucocyte responses induced by platelet activating factor in man. 1989 Thorax pmid:2648645
Chung KF and Barnes PJ Effects of platelet activating factor on airway calibre, airway responsiveness, and circulating cells in asthmatic subjects. 1989 Thorax pmid:2648646
Summers C et al. Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome. 2014 Thorax pmid:24706039
Spencer DA et al. Participation of the cysteinyl leukotrienes in the acute bronchoconstrictor response to inhaled platelet activating factor in man. 1991 Thorax pmid:1858084
Freitag A et al. Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses. 1993 Thorax pmid:8346486
Hoenderdos K et al. Hypoxia upregulates neutrophil degranulation and potential for tissue injury. 2016 Thorax pmid:27581620
Alabaster VA and Moore BA New perspectives on basic mechanisms in lung disease. 3. Drug intervention in asthma: present and future. 1993 Thorax pmid:8493636
Roudebush WE and Diehl JR Platelet-activating factor content in boar spermatozoa correlates with fertility. 2001 Theriogenology pmid:11396471
O' Meara CM et al. Relationship between in vitro sperm functional tests and in vivo fertility of rams following cervical artificial insemination of ewes with frozen-thawed semen. 2008 Theriogenology pmid:18248736
Bathgate R et al. Effects of platelet-activating factor and platelet-activating factor: acetylhydrolase on in vitro post-thaw boar sperm parameters. 2007 Theriogenology pmid:17157372
Kumar S and Sharma A Platelet activating factor improves the in vitro penetration of zona free hamster eggs by buffalo (Bubalus bubalis) spermatozoa. 2005 Theriogenology pmid:15763101
Desquand S [Effects of PAF antagonists in experimental models. Therapeutical perspectives]. 1993 Nov-Dec Therapie pmid:8091344
Zardini DM and Tschirhart EJ [Selective differentiation and proliferation of human eosinophils from umbilical cord blood: calcium fluxes and superoxide ion secretion]. 1999 Jan-Feb Therapie pmid:10216433
Willerson JT Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products. 1995 Tex Heart Inst J pmid:7787465
TatarskiÄ­ AR et al. [Use of plateletpheresis in the treatment of bronchial asthma]. 1991 Ter. Arkh. pmid:2063345
TatarskiÄ­ AR and Emirova AS [The role of the thrombocytes in the pathogenesis of certain forms of bronchial asthma]. 1990 Ter. Arkh. pmid:2142338
Skvortsov AA et al. [New approaches to the study of thrombocyte aggregation in patients with dilated cardiomyopathy]. 1989 Ter. Arkh. pmid:2727928
Miwa M [Catabolism of PAF and its regulation]. 1991 Tanpakushitsu Kakusan Koso pmid:2024018
Oda M et al. [PAF and diseases]. 1991 Tanpakushitsu Kakusan Koso pmid:2024019
Fukuda T and Makino S [Allergy and PAF]. 1991 Tanpakushitsu Kakusan Koso pmid:2024020
Yanoshita R [Phospholipid alteration and activation of phospholipase A2 in ischemic heart]. 1991 Tanpakushitsu Kakusan Koso pmid:2024024
Karasawa K and Nojima S [Production and application of antibodies to PAF]. 1991 Tanpakushitsu Kakusan Koso pmid:2024029
Tsujimoto M and Hori T [Activation of phospholipase A2 by cytokines]. 1991 Tanpakushitsu Kakusan Koso pmid:2024038
Ishii S and Shimizu T [Platelet-activating factor (PAF) receptor-related pathophysiology]. 1999 Tanpakushitsu Kakusan Koso pmid:10396985
Okiji T and Murota S [Chemical mediators]. 1991 Tanpakushitsu Kakusan Koso pmid:1901997
Mizoguchi H [Erythropoietin and thrombopoietin]. 1991 Tanpakushitsu Kakusan Koso pmid:1651533
Shindou H and Shimizu T [New development of lysophospholipid acyltransferases]. 2009 Tanpakushitsu Kakusan Koso pmid:19205351
Karasawa K [Physiological role of novel metabolic pathway of platelet-activating factor(PAF): PAF-dependent transacetylation]. 2001 Tanpakushitsu Kakusan Koso pmid:11193332
Masugi F et al. [Platelet-activating factor and antihypertensive polar renomedullary lipid: 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine]. 1982 Tanpakushitsu Kakusan Koso pmid:6758041
Terasawa M [Platelet-activating factor (PAF) antagonists]. 1991 Tanpakushitsu Kakusan Koso pmid:1850862
Eser A et al. Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients. 2016 Taiwan J Obstet Gynecol pmid:26927250
Bazan NG and Allan G Signal transduction and gene expression in the eye: a contemporary view of the pro-inflammatory, anti-inflammatory and modulatory roles of prostaglandins and other bioactive lipids. 1997 Surv Ophthalmol pmid:9154273
Abu-Zidan FM Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock. 1998 Surgery pmid:9481416
Botha AJ et al. Postinjury neutrophil priming and activation: an early vulnerable window. 1995 Surgery pmid:7638753
Werner J et al. Multidrug strategies are effective in the treatment of severe experimental pancreatitis. 2012 Surgery pmid:21982067
Biffl WL et al. Clinically relevant hypertonicity prevents stored blood- and lipid-mediated delayed neutrophil apoptosis independent of p38 MAPK or caspase-3 activation. 2003 Surgery pmid:12874587
Partrick DA et al. Nitric oxide attenuates platelet-activating factor priming for elastase release in human neutrophils via a cyclic guanosine monophosphate-dependent pathway. 1997 Surgery pmid:9288123
Porras-Reyes BH and Mustoe TA Platelet-activating factor: improvement in wound healing by a chemotactic factor. 1992 Surgery pmid:1557687
Liu T et al. Improved preservation of the rat liver for orthotopic liver transplantation: use of University of Wisconsin-lactobionate solution and retrograde reflushing. 1990 Surgery pmid:2237771
Wang KS et al. Protective effect of platelet-activating factor antagonist on ischemia-induced liver injury in rats. 1993 Surgery pmid:8417492